26 June 2020Big PharmaRory O'Neill

LSPN Connect: MPP chief wants COVID-19 role

The executive director of the Medicines Patent Pool (MPP) says it should have a role in fighting COVID-19, but it’s up to stakeholders to agree what that will be.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

US to pay Pfizer nearly $2bn for COVID-19 vaccine supply

23 July 2020 Pfizer and its German partner BioNTech will receive nearly $2 billion from the US in exchange for the supply of 100 million doses of an experimental coronavirus vaccine.

Americas

LSPN Connect: CRISPR, IP headaches and ‘deplorable’ diversity

31 July 2020 The development of CRISPR technology is showing no signs of losing momentum, and Arbor Biotechnologies is one company that is taking full advantage of this. We spoke to Kelly Morgan, senior director, head of IP and legal at the company to find out more.

Biotechnology

LSPN Connect: micro-managing with Pendulum Therapeutics

6 August 2020 With any rapidly-developing field, particularly the life sciences, the importance of a coherent IP strategy cannot be ignored.

More on this story

Americas

US to pay Pfizer nearly $2bn for COVID-19 vaccine supply

23 July 2020 Pfizer and its German partner BioNTech will receive nearly $2 billion from the US in exchange for the supply of 100 million doses of an experimental coronavirus vaccine.

Americas

LSPN Connect: CRISPR, IP headaches and ‘deplorable’ diversity

Biotechnology

LSPN Connect: micro-managing with Pendulum Therapeutics

6 August 2020 With any rapidly-developing field, particularly the life sciences, the importance of a coherent IP strategy cannot be ignored.

More on this story

Americas

US to pay Pfizer nearly $2bn for COVID-19 vaccine supply

23 July 2020 Pfizer and its German partner BioNTech will receive nearly $2 billion from the US in exchange for the supply of 100 million doses of an experimental coronavirus vaccine.

Americas

LSPN Connect: CRISPR, IP headaches and ‘deplorable’ diversity

Biotechnology

LSPN Connect: micro-managing with Pendulum Therapeutics

6 August 2020 With any rapidly-developing field, particularly the life sciences, the importance of a coherent IP strategy cannot be ignored.